Read + Share
Lu C, Wei XW, Zhang YC, Chen ZH, et al. Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC
and improve survival outcomes. J Cancer Res Clin Oncol 2023;149:2987-2995.
PMID: 35838839
|
 |
|
Lu C, Wei XW, Zhang YC, Chen ZH, et al. Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC
and improve survival outcomes. J Cancer Res Clin Oncol 2023;149:2987-2995.
PMID: 35838839
|
|
|
|